In this study we demonstrate that, in addition to blood, ␣ 1 -microglobulin ( ␣ 1 m) is present in most tissues, including liver, heart, eye, kidney, lung, pancreas, and skeletal muscle. Western blotting of perfused and homogenized rat tissue supernatants revealed ␣ 1 m in its free, monomeric form and in high molecular weight forms, corresponding to the complexes fibronectin-␣ 1 m and ␣ 1 -inhibitor-3-␣ 1 m, which have previously been identified in plasma. The liver also contained a series of ␣ 1 m isoforms with apparent molecular masses between 40 and 50 kD. These bands did not react with anti-inter-␣ -inhibitor antibodies, indicating that they do not represent the ␣ 1 m-bikunin precursor protein. Similarly, the heart contained a 45-kD ␣ 1 m band and the kidney a 50-kD ␣ 1 m band. None of these ␣ 1 m isoforms was present in plasma. Immunohistochemical analysis of human tissue demonstrated granular intracellular labeling of ␣ 1 m in hepatocytes and in the proximal epithelial cells of the kidney. In addition, ␣ 1 m immunoreactivity was detected in the interstitial connective tissue of heart and lung and in the adventitia of blood vessels as well as on cell surfaces of cardiocytes. ␣ 1 m mRNA was found in the liver and pancreas by polymerase chain reaction, suggesting that the protein found in other tissues is transported via the bloodstream from the production sites in liver and pancreas. The results of this study indicate that in addition to its role in plasma, ␣ 1 m may have important functions in the interstitium of several tissues. (J Histochem Cytochem 46:887-893, 1998)
␣ 1 -M icroglobulin ( ␣ 1 m) is a yellow-brown 26-kD glycoprotein which was originally isolated from the urine of patients with renal defects (Ekström et al. 1975; Tejler et al. 1976; Ekström and Berggård 1977) . ␣ 1 m is a member of the lipocalin superfamily, which now includes approximately 25 members (Flower 1996) . Retinol binding protein (RBP), ␣ 1 -acid glycoprotein (orosomucoid), and prostaglandin D-synthase are other members of this family and, like ␣ 1 m, are predominantly extracellular proteins. A majority of the lipocalins bind and transport specific small hydrophobic substances, such as retinoids and steroids, in a hydrophobic pocket. This pocket is formed by eight antiparallel ␤ -strands folded into a ␤ -barrel, lined on the inside by hydrophobic residues that specify the ligand specificity of each lipocalin (Papiz et al. 1986; Cowan et al. 1990 ). The biological significance of the homology between ␣ 1 m and the other lipocalins is presently not known because the binding specificity of ␣ 1 m has not been identified.
␣ 1 m has a strong tendency to form complexes with other proteins. In human and rat, approximately half of the plasma ␣ 1 m exists as high molecular weight forms, which are too large to escape from the circulation via glomerular filtration. Curiously, the ␣ 1 m complexes that have been found thus far in human plasma are not found in rat plasma, and vice versa. ␣ 1 m has been shown to be complexed with IgA, prothrombin, and albumin in humans (Tejler et al. 1976; Grubb et al. 1983; Berggård et al. 1997) and with fibronectin and the ␣ 2 -macroglobulin homologue ␣ 1 -inhibitor-3 in rats (Falkenberg et al. 1990 (Falkenberg et al. ,1994 . The sites of formation and metabolism of these high molecular weight ␣ 1 m complexes are unknown, but the ␣ -inhibitor-3-␣ 1 m complex was shown to be rapidly cleared from the circulation (Falkenberg et al. 1995) .
The gene for ␣ 1 m has been isolated and characterized (Diarra-Mehrpour et al. 1990; Vetr and Gebhard 1990) and encodes two tandemly arranged proteins, ␣ 1 m and bikunin (Kaumeyer et al. 1986 ). Bikunin is the light chain found in the plasma proteins inter-␣ -inhibitor, pre-␣ -inhibitor, and heavy chain 2-bikunin (Enghild et al. 1989 ). The bikunin subunit is responsible for the proteinase inhibitory activities of these proteins. Bikunin also apparently stimulates the growth of normal endothelial cells (McKeehan et al. 1986 ) and fibroblasts (Perry et al. 1994) . Moreover, inter-␣ -inhibitor has been shown to be an important component for the formation of the extracellular matrix (Chen et al. 1992; Blom et al. 1995) .
When synthesized, a precursor protein is translated in which ␣ 1 m and bikunin are connected by a short peptide. The precursor is cleaved into the two mature proteins before secretion (Bratt et al. 1993 (Bratt et al. ,1994 Thøgersen and Enghild 1995) . The co-expression of ␣ 1 m and bikunin is conserved in all species examined to date (from fish to human) (Hanley and Powell 1994; Leaver et al. 1994) . This suggests that the two proteins are involved in common processes. However, thus far no functional relation has been shown between ␣ 1 m and bikunin in plasma. ␣ 1 m has been extensively studied in blood, but although different immunoregulatory properties have been reported for ␣ 1 m (for reviews see Åkerström and Lögdberg 1990; Åkerström 1992) , the physiological function of the protein is still unclear.
␣ 1 m is generally considered to be a plasma protein, but the result reported in this study reveals that ␣ 1 m is present in the extracellular matrix of many tissues. Moreover, ␣ 1 m is not generally synthesized in the tissues but mainly in the liver, and is probably transported to the tissues across the endothelial cell membrane by an unknown mechanism. In addition, both high and low molecular weight forms of ␣ 1 m are widely distributed in the matrix of tissues, suggesting a possible function in these interstitial tissue domains.
Materials and Methods

Materials
The general serine-proteinase inhibitor 3,4-dichloroisocoumarin (DCI) and the general cysteine-proteinase inhibi-
amino]-butyl]-guanidine (E-64) were from Boehringer-Mannheim (Indianapolis, IN). Goat anti-rabbit IgG-alkaline phosphatase-conjugated antiserum, 1,10-phenanthroline bromochloroindolyl phosphate, and nitroblue tetrazolium were purchased from Sigma (St Louis, MO). Rabbit antisera against human ␣ 1 m were purchased from Accurate Chemical and Scientific (Westbury, NY). Rat plasma was obtained from Pel-Freeze Biologicals, (Rogers, AR). The rabbit antiserum against rat ␣ 1 m was prepared as described previously (Åkerström and Landin 1985) . Human ␣ 1 m was purified from the urine of patients with tubular proteinuria as described (Åkerström et al. 1995) . Rat ␣ 1 -inhibitor-3 was purified as reported earlier (Enghild et al. 1989 ). Sprague-Dawley rats were from Charles Rivers (Wilmington, MA). Human tissue samples for immunohistochemistry and PCR analysis were obtained at autopsy by the Department of Pathology, Duke University Medical Center (Durham, NC) and were histologically determined to be normal.
SDS-polyacrylamide Gel Electrophoresis
Aliquots of the supernatant from each of the homogenized tissue samples were subjected to SDS-PAGE under nonreducing conditions. This was performed in 5-15% linear gradient gels using the glycine-2-amino-2-methyl-1,3-propanediol-HCl system described by Bury (1981) . Molecular mass standards were rat ␣ 1 -inhibitor-3 (180 kD) mixed with Bio-Rad (Hercules, CA) low molecular weight mass standard, visualized by staining with Coomassie Brilliant Blue.
Western Blot Analysis
Proteins were separated by SDS-PAGE and transferred to polyvinylidene diflouride membrane (PVDF) as described by Matsudaira (1987) . All subsequent steps were performed on a rotating table at 25C. The membrane was equilibrated in 20 ml of 10 mM Tris-HCl, 0.15 mM NaCl, and 0.05% NP-40 (TSN buffer) containing 1% bovine albumin for 30 min before the addition of 10 l ␣ 1 m antiserum (1:2000 dilution). After 1 hr the membrane was washed twice in TSN buffer and twice in 10 mM Tris-HCl, 10 mM NaCl, pH 7.5 (TS buffer) for 5 min each. Then 20 ml of TSN buffer containing 10 l anti-rabbit IgG-alkaline phosphatase conjugate (1:2000 dilution) was allowed to react for 30 min before the membrane was washed as above. The substrates bromochloroindolyl phosphate and nitroblue tetrazolium were added and color was allowed to develop in the dark for up to 30 min. The reaction was stopped with 5 mM EDTA in TS buffer.
Perfusion of Rat Tissues
Sprague-Dawley rats were anesthetized by IP injection with pentobarbital. After sedation they were opened and one lung was removed. A blood sample was taken from the left ventricle of the heart, and the animal perfused via the same needle, using 500 ml of 0.9% normal saline. Perfusion of the lungs was performed by infusion of 100 ml of 0.9% saline through the right ventricle of the heart after cutting the abdominal aorta. The organs were removed, weighed, and homogenized in a high-speed homogenizer (Cole-Parmer Instruments; Niles, IL) in 100 mM NaCl, 50 mM ( N -
-butyl]-guanidine (E-64) (10 ml/g). The homogenates were then centrifuged at 2500 rpm for 15 min and the supernatant was collected.
Immunohistochemistry
Human tissues were fixed in 10% formalin followed by routine processing and paraffin embedding. Sections were then labeled for antigen using an indirect immunoperoxidase method (Milde et al. 1989; Randell et al. 1991 ) with a biotinylated goat anti-rabbit IgG and streptavidin-horseradish peroxidase. To reduce background staining, the sections were incubated in 1% H 2 O 2 in methanol to inactivate endogenous peroxidases and 10 mM borohydride to block aldehydes. Nonspecific binding was blocked by incubation with 5% normal goat serum (NGS), 5% milk, and 1% BSA in PBS. Primary and secondary antibody dilutions were determined empirically and made in PBS with 1% milk plus 1% BSA (milk was not included in the streptavidin solution). The slides were developed using diaminobenzidine (10 mg diaminobenzidine, 50 ml 0.05 M Tris-Cl, pH 7.6, 100 ml 3% H 2 O 2 ) and counterstained with hematoxylin.
As a control, one serial section on each slide was incubated with preimmune rabbit serum or with anti-␣ 1 m antibodies absorbed by immunosorbent affinity chromatography. The latter was done by immobilizing 1 mg of purified ␣ 1 m to 1 ml CNBr-activated Sepharose according to the manufacturer's instructions (Sigma). The affinity gel was then incubated for 24 hr with 1 ml of primary antibodies at two times the concentration used for immunolabeling. The supernatant was then used for immunohistochemistry.
Reverse Transcriptase PCR
The presence of mRNA in the tissue was examined by extracting RNA essentially as described previously (Chomczynski and Sacchi 1987) followed by RT-PCR. This method involves a single acid guanidium thiocyanate-phenol-chloroform RNA extraction followed by an acid phenol extraction and incubation with RNase-free DNase. The sample is subsequently extracted with acid phenol and ␣ 1 m-bikunin RNA is amplified with specific primers using a thermocycler (Perkin-Elmer Cetus GeneAmp PCR system 9600; Norwalk, CT) and appropriate reagents (Gene Amp, EZ rTth RNA PCR kit). The ␣ 1 m-specific primers were 5 Ј tgctgggagagggcgctaca3 Ј (forward) and 5 Ј gcccatgcagccgccgtact 3Ј (reverse). The expected 593-bp product was generated by first incubating at 30 min at 60C and 1 min at 94C followed by 40 cycles at 94C for 15 sec and 70C at 30 sec. As a positive control, RT-PCR was performed on all tissues using primers specific for glyceraldehyde 3-phosphate dehydrogenase. The product was generated by first incubating at 30 min at 60C and 100 sec at 94C followed by 40 cycles at 94C for 15 sec and 69C at 30 sec. Presence of the predicted 336-bp product ensured that negative results for ␣ 1 m-bikunin RNA were not due to RNA degradation in the tissue.
Results
Identification of ␣ 1 m in Perfused Rat Tissue Perfused rat tissues were homogenized and insoluble debris was removed by centrifugation. Aliquots of the supernatants were analyzed by SDS-PAGE, followed by Western blotting using anti-rat ␣ 1 m antiserum. The distributions of the different ␣ 1 m species in rat plasma and in the perfused rat tissues were compared ( Figure  1A) . In plasma, several ␣ 1 m-immunoreactive bands with apparent molecular masses of 28, 43, 75, 110, , and 240 kD were evident. These bands specifically reacted with rat ␣ 1 m antisera ( Figure 1B) . The 28-kD band is free uncomplexed rat plasma ␣ 1 m and the 240-kD and 180-210 kD bands represent the fibronectin-␣ 1 m and ␣ 1 -inhibitor-3-␣ 1 m complexes, respectively (Falkenberg et al. 1990 (Falkenberg et al. ,1994 . The 43-kD band has not been characterized. The 240-and 180-210 kD bands were seen in most tissues. It is likely that these also represent fibronectin-␣ 1 m and ␣-inhibitor-3-␣ 1 m. The 180-210 kD ␣-inhibitor-3-␣ 1 m complex was absent from the liver, and the 240-kD fibronectin-␣ 1 m complex was absent from the lung and pancreas. As discussed previously, the 110-and 75-kD bands are most likely degradation products of the two complexes (Falkenberg et al. 1990 (Falkenberg et al. ,1994 .
Some tissues contained forms of ␣ 1 m that were not found in plasma. The liver contained five ␣ 1 m isoforms with molecular masses between 40 and 50 kD. The 50-kD ␣ 1 m isoform was also present in the kidney, and the heart contained a slightly smaller 45-kD isoform. The pancreas and the eye contained more free ␣ 1 m relative to the larger complexes than the other tissues. The 18-kD band observed in the eye homogenate represented a nonspecific reaction because it Figure 1 Identification of ␣ 1 m in rat tissues. A rat was perfused and the organs were removed and homogenized in 50 ml of a buffer (100 mM NaCl, 50 mM HEPES, containing 100 mM DCI, 500 mM 1,10-phenanthroline, and 50 mM E-64). The homogenized organs were centrifuged and portions of the supernatants were subjected to nonreducing SDS-PAGE followed by immunoblotting with anti-rat ␣ 1 m antiserum (A) or a preimmune antiserum (B). The ␣ 1 m related bands identified previously in rat plasma are indicated. The molecular mass markers are indicated in kD.
was present even when the primary antiserum was omitted (not illustrated). The brain contained only the 110-kD band. Western blotting of the same samples using an antibody against a control plasma protein yielded the expected band in plasma, whereas other tissue samples were negative (not shown). This shows that the ␣ 1 m bands in the tissues did not originate from plasma contamination.
Immunochemical Localization of ␣ 1 m Proteins in Human Tissues
To investigate the tissue distribution of the ␣ 1 m proteins, we obtained paraffin-embedded sections of human tissue, including heart, liver, lung, and kidney.
These tissue sections were labeled with antisera to ␣ 1 m and detected using a biotin-streptavidin-horseradish peroxidase technique. The studies revealed a granular, cytoplasmic labeling for ␣ 1 m in the liver (Figure 2A ). This is expected because hepatocytes have been shown to be the primary site of ␣ 1 m synthesis (Salier et al. 1987 (Salier et al. ,1993 Lindqvist et al. 1992; Chan et al. 1995) . In addition, labeling for ␣ 1 m was present in the proximal tubules of the kidney (Figure 2G ). This result is also expected because ␣ 1 m is known to be filtered by the glomeruli and reabsorbed in the tubules. Immunochemical staining of the heart and lung also demonstrated positive labeling for ␣ 1 m, supporting the results of Western blot analysis of these tissues ( Figure  1) . Specifically, labeling for ␣ 1 m was found in the ex-
Figure 2
Immunochemical localization of ␣ 1 m in human tissues. Sections of human kidney, heart, liver, and lung were labeled with an antibody to ␣ 1 m or with nonimmune serum, and the antibody was detected using a biotin-streptavidin-horseradish peroxidase technique. (A) Liver: punctate granular labeling for ␣ 1 m is present in the cytoplasm of hepatocytes. (B) Heart: labeling for ␣ 1 m is also found in the adventitial matrix of blood vessels in the heart (arrow). (C) Heart: in addition, labeling for ␣ 1 m is present on the membrane surface of cardiocytes (brown labeling). (D) Heart: no labeling is present when nonimmune serum is substituted for the primary antibody for ␣ 1 m. (E) Lung: ␣ 1 m is found in the matrix surrounding airways (arrow). (F) Lung: in addition, labeling for ␣ 1 m is present in alveolar septa (arrow) and in the matrix of small blood vessels (*). (G) Kidney: immunochemical labeling for ␣ 1 m in the kidney is present within the cytoplasm of proximal tubule epithelial cells (brown color). No intracellular labeling is observed in glomeruli (*) or in distal tubule epithelium. (H) Kidney: no labeling is present when nonimmune serum is substituted for the primary antibody for ␣ 1 m. Bars ϭ 100 m. tracellular matrix of blood vessels in the heart ( Figure  2B ), lung ( Figure 2F) , liver, and kidney (not illustrated). Furthermore, ␣ 1 m was also present on the cell surface of cardiocytes in the heart ( Figure 2C ) and within the matrix of alveolar septa and airways in the lung (Figures 2E and 2F) . No labeling was observed when nonimmune serum was substituted for the primary antibody or when antibodies were absorbed with purified ␣ 1 m (Figures 2D and 2H) . These results indicate that the labeling was specific for ␣ 1 m.
Reverse Transcriptase PCR
The results described above show that ␣ 1 m is distributed throughout the body. To determine if the protein was made locally, we examined tissue samples for the presence of ␣ 1 m mRNA. Appropriate primers were designed as described above and reverse transcriptase PCR was performed on mRNA extracted from the following human tissues: liver, kidney, lung, heart, spleen, muscle, thyroid, pancreas, and adrenal gland. Figure 3 shows that only the liver and the pancreas produced ␣ 1 m RNA. The 0.6-kb PCR band was much weaker in pancreas, suggesting a lower rate of gene transcription and protein synthesis in pancreas than in liver. All tissues contained mRNA for glyceraldehyde 3-phosphate dehydrogenase, indicating that the lack of ␣ 1 m mRNA was not due to RNA degradation. These results indicate that ␣ 1 m present in the other tissues is not locally synthesized but is produced mainly in the liver, secreted into the blood, and transported to the tissues from the plasma by an unknown mechanism.
Discussion
Previous studies have demonstrated ␣ 1 m immunoreactivity in skin, colon, testis, and ovary (Bouic et al. 1984; Nielsen 1994,1997) . We have shown that ␣ 1 m is also present in many other tissues, including liver, heart, eye, kidney, brain, lung, pancreas, and skeletal muscle. An intense granular intracellular labeling was observed in hepatocytes, consistent with production and secretion by these cells. Intracellular ␣ 1 m labeling was also observed in the proximal tubule cells of the kidney. This was expected because the small size of ␣ 1 m promotes uptake, reabsorbance and degradation by the kidneys (Strober and Waldmann 1974; Tejler et al. 1978; Salier et al. 1987 Salier et al. ,1993 Lindqvist et al. 1992; Chan et al. 1995) . Other ␣ 1 mcontaining tissues did not show any intracellular labeling but instead demonstrated widespread staining in the interstitial connective tissue matrix. For example, the matrix of blood vessels and the matrix of alveolar septa and airways in the lung were labeled by anti-␣ 1 m.
Most of the known plasma proteins, except the immunoglobulins, are synthesized by hepatocytes. In some cases, additional synthesis of plasma proteins takes place in other cell types (Lamontagne et al. 1985; Campbell and Law 1992) . The synthesis by these cells is often minor compared to the synthesis by the hepatocytes. ␣ 1 m has been reported to be synthesized by the liver (Åkerström and Landin 1985; Salier et al. 1987 Salier et al. ,1993 Lindqvist et al. 1992; Chan et al. 1995) . Other organs, such as kidney in rat and plaice (Karsten et al. 1986; Leaver et al. 1994) , stomach in pig (Tavakkol 1991) , blood cells in plaice (Leaver et al. 1994) , and pancreas in humans (Itoh et al. 1996) , have also been suggested to produce ␣ 1 m. In the present study, done on human tissue, ␣ 1 m mRNA was detected in the liver and, to a lesser extent, in the pancreas, suggesting that human ␣ 1 m is mainly produced in the liver, but with a minor contribution from the pancreas. The presence of ␣ 1 m in pancreas is presently being investigated by immunohistochemical and biochemical analyses (Lögdberg et al., manuscript in preparation) . All other organs in which staining by anti-␣ 1 m was demonstrated lacked ␣ 1 m mRNA. The ␣ 1 m present in the interstitial connective tissue matrix of different organs is therefore most likely not synthesized locally but is transported to these compartments from blood. This is supported by the fact that although the ␣ 1 m-bikunin mRNA content is elevated during inflammation, the total plasma concentrations and urinary excretion of bikunin and ␣ 1 m remain unchanged .
␣ 1 m is found in plasma both as a monomer and in complexes with other plasma proteins. These plasma complexes are mainly covalent and have previously been analyzed (Grubb et al. 1983; Falkenberg et al. 1990 Falkenberg et al. ,1994 Berggård et al. 1997) . The biosynthesis and the site of formation of the high molecular weight ␣ 1 m complexes are not known. Many low molecular mass plasma proteins are rapidly eliminated from plasma by glomerular filtration. In some cases, the Expression of ␣ 1 m. Total RNAs were extracted from the indicated tissues. The extracted RNA was reverse-transcribed and amplified by RT-PCR using primers specific for ␣ 1 m mRNA. The PCR products were electrophoresed in a 2% agarose gel and stained with the ethidium bromide. ␣ 1 m is secreted by the liver and the 593-bp product was detected as expected. The mRNA was also detected in the pancreas, but all other tissues examined did not appear to contain ␣ 1 m mRNA. low molecular weight proteins are complex-bound to larger proteins in plasma, resulting in a slower elimination time (Cowan et al. 1990 ). In accordance with this, it has been speculated that one purpose of the complex formation between ␣ 1 m and other plasma proteins may be to prevent loss of ␣ 1 m by filtration through the kidney glomeruli (Berggård et al. 1997) . The molecular mass of each protein also determines the extent of passive exchange between the intercellular space and plasma. Although larger proteins are less likely to passively penetrate the endothelium of blood vessels, we detected higher levels of high molecular weight ␣ 1 m, relative to free ␣ 1 m in the tissues. In addition, the brain contained high molecular weight ␣ 1 m, although plasma proteins are unable to cross the blood-brain barrier. These findings suggest that the transport from the blood to the tissues is receptormediated.
The results reported here indicate that the biodistribution of ␣ 1 m is not restricted to blood. In fact, ␣ 1 m is widely distributed in the interstitial matrices and appears to form tissue-specific complexes with other proteins that are not found in plasma. Therefore, ␣ 1 m could be regarded as a matrix protein in addition to its previous categorization as a plasma protein. Several possible functions for tissue ␣ 1 m can be envisioned. As speculated previously Nielsen 1994,1997; Falkenberg et al. 1997) , it is possible that the immunosuppressive effects of ␣ 1 m, i. e., the inhibition of lymphocyte proliferation and granulocyte chemotaxis and migration, protect "bystander" interstitial tissue from the immune and inflammatory reactions. Furthermore, ␣ 1 m is a member of the lipocalin superfamily. Most of the lipocalins are carriers of small hydrophobic prosthetic groups such as retinol, pheromones, odorants, bilirubin, and steroids (Flower 1996) . It can be speculated that ␣ 1 m is a transporter of such small prosthetic groups from blood to tissues. This would be in agreement with ␣ 1 m being synthesized mainly in the liver but found in most organs. Finally, the specific presence of ␣ 1 m around blood vessels and in lung airways and alveolar septa resembles that of extracellular superoxide dismutase (EC-SOD), a scavenger of the superoxide anion (Oury et al. 1994 ). This protein is believed to be important in the defense against superoxide-mediated tissue damage. A similar protective role for ␣ 1 m in these domains is possible, as an immunoprotective agent, as a potential scavenger of small toxic substances, or both.
